Shandong New Time Pharmaceutical

CompanyChina

Shandong New Time Pharmaceutical develops one asset, in phase 2 (F520 in cancer of unknown primary site). Mostly small molecule; based in China.

1
Asset
Furthest stage
Phase 2
5
Trials
1
Signal

Pipeline

1
  • F520

    Phase 2, Small molecule, cancer of unknown primary site

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Evidence behind the mechanisms1
  • Trials5
  • Signals1
  • Similar companies5

Intelligence